INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Lobbying registrant
TG

TODD STRATEGY GROUP

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections24with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    BIOGEN INC.LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    Apollo Global Management, Inc.LDA Q2 2026 second quarter · Financial institutions · Aug 26, 2026
  • Lobbied forevidence
    MCKESSON CORPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    EXELIXIS, INC.LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid, Copyright/patent · Aug 26, 2026
  • Lobbied forevidence
    MYRIAD GENETICS INCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    BIODESIX INCLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    ALNYLAM PHARMACEUTICALS, INC.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Fox CorpLDA Q1 2026 first quarter · COM · Aug 26, 2026
  • Lobbied forevidence
    ASTRAZENECA PLCLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    Merck & Co., Inc.LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    INSULET CORPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    ELI LILLY & CoLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Guardant Health, Inc.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    Vaxart, Inc.LDA Q2 2026 second quarter · MED · Aug 26, 2026
  • Lobbied forevidence
    Alkermes plc.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    GSK plcLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    CareDx, Inc.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    COMPASS Pathways plcLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    NOVARTIS AGLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
  • Lobbied forevidence
    AMGEN INCLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues, Taxation · Aug 26, 2026
  • Lobbied forevidence
    BRISTOL MYERS SQUIBB COLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    PFIZER INCLDA Q1 2026 first quarter · Pharmacy, TAR, Trade · Aug 26, 2026
  • Lobbied forevidence
    ILLUMINA, INC.LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
  • Lobbied forevidence
    GILEAD SCIENCES, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026